Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

RESMED, INC.

(RMD)
  Report
Real-time Estimate Cboe BZX  -  11:11 2022-11-30 am EST
223.90 USD   +0.31%
11/23Insider Sell: Resmed
MT
11/22ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions
GL
11/22ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Days
:
Hours
:
Minutes
:
Seconds
Most relevant news about RESMED, INC.
11/23Insider Sell: Resmed
MT
11/22ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Ma..
GL
11/22ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Ma..
AQ
11/17Resmed : Submission of Matters to a Vote of Security Holders - Form 8-K
PU
11/17ResMed Inc Provides Information to the Shareholders
CI
11/17Insider Sell: Resmed
MT
11/16ResMed Opens Manufacturing Centre in Singapore, Expanding Manufacturing Footprint to Su..
CI
11/16Resmed Inc. Appoints Sandeep Gulati as General Manager, South Asia
CI
11/16Resmed : Opens Manufacturing Centre in Singapore, Expanding Manufacturing Footprint to Sup..
PU
11/14Insider Sell: Resmed
MT
11/09Insider Sell: Resmed
MT
11/09RESMED, INC. : Ex-dividend day for
FA
11/02Insider Sell: Resmed
MT
10/30Morgans rates RMD as Add
AQ
10/28RBC Lifts Price Target on ResMed to $254 From $252, Maintains Sector Perform Rating
MT
10/28KeyBanc Adjusts ResMed's Price Target to $280 From $276, Keeps Overweight Rating
MT
10/27ResMed Posts Flat Fiscal Q1 Adjusted EPS, Higher Revenue; Quarterly Dividend Maintained..
MT
10/27Resmed : Fiscal Q1 Earnings Snapshot
AQ
10/27Transcript : ResMed Inc., Q1 2023 Earnings Call, Oct 27, 2022
CI
10/27ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2023
GL
10/27ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2023
AQ
10/27ResMed Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022
CI
10/27ResMed Inc. Declares Quarterly Cash Dividend, Payable on December 15, 2022
CI
10/27Earnings Reaction History: Resmed Inc, 75.0% Follow-Through In..
MT
10/20BofA Securities Upgrades ResMed to Buy From Neutral, Adjusts Price Target to $260 From ..
MT
10/18Insider Sell: Resmed
MT
10/18Insider Sell: Resmed
MT
10/14Universitat De Barcelona : RESMED project proposes new fishing management tools for the Py..
AQ
10/13ResMed to Report First Quarter Fiscal 2023 Earnings on October 27, 2022
GL
10/13ResMed to Report First Quarter Fiscal 2023 Earnings on October 27, 2022
GL
10/12Jefferies Starts ResMed at Hold With $245 Price Target
MT
10/05Insider Sell: Resmed
MT
09/19Insider Sell: Resmed
MT
09/14Transcript : ResMed Inc. Presents at BofA Securities Global Healthcare Confer..
CI
09/12Transcript : ResMed Inc. Presents at Morgan Stanley 20th Annual Global Health..
CI
09/09North American Morning Briefing: Stocks to Gain; -2-
DJ
09/07Insider Sell: Resmed
MT
09/07ResMed Announces Participation in the Bank of America Global Healthcare Conference
GL
09/07ResMed Announces Participation in the Bank of America Global Healthcare Conference
GL
09/06ResMed Announces Participation in the 20th Annual Morgan Stanley Global Healthcare Conf..
GL
09/06ResMed Announces Participation in the 20th Annual Morgan Stanley Global Healthcare Conf..
GL
09/04Over 480 Million People Estimated to Have COPD, World's Third Deadliest Disease, ResMed..
AQ
09/04Over 480 Million People Estimated to Have COPD, World's Third Deadliest Disease, ResMed..
GL
08/21Explainer-What is the impact of Philips' recall of sleep apnea devices?
RE
08/17FDA says faulty Philips device reports accelerating as CEO departs
RE
08/17RESMED, INC. : Ex-dividend day for
FA
08/16What do investors want?
MS
08/16Analyst recommendations: Visa, Mastercard, ResMed, Extra Space S..
MS
08/15Morgan Stanley rates RMD as Equal-weight
AQ
08/15North American Morning Briefing: Stock Futures -3-
DJ
08/12Illumina, ResMed fall; Broadridge, Humana rise
AQ
08/12Insider Sell: Resmed
MT
08/12Morgan Stanley Adjusts Price Target for ResMed to $222 From $204, Maintains Equalweight..
MT
08/12JPMorgan Downgrades ResMed to Neutral From Overweight, Lowers Price Target to $250 From..
MT
08/12RBC Downgrades ResMed to Sector Perform From Outperform, Citing Valuation, But Lifts Pr..
MT
08/12Citigroup Downgrades ResMed to Neutral From Buy
MT
08/12Resmed : Regulation FD Disclosure - Form 8-K/A
PU
08/12Resmed : Annual Report for Fiscal Year Ending June 30, 2022 (Form 10-K)
PU
08/12Tranche Update on ResMed Inc.'s Equity Buyback Plan announced on February 27, 2014.
CI
08/12Resmed Fiscal Q4 Profit Flat, But Revenue Rises
MT
08/11Resmed : 4Q22 Earnings Presentation
PU
08/11Resmed : Announces Results for the Fourth Quarter of Fiscal Year 2022 - Form 8-K
PU
08/11ResMed Fiscal Q4 Non-GAAP EPS, Revenue Rise; Increases Quarterly Dividend
MT
08/11Resmed : Fiscal Q4 Earnings Snapshot
AQ
08/11ResMed Seeks Tuck-In Acquisitions
CI
08/11Transcript : ResMed Inc., Q4 2022 Earnings Call, Aug 11, 2022
CI
08/11ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2022
GL
08/11ResMed Inc. Reports Earnings Results for the Full Year Ended June 30, 2022
CI
08/11ResMed Inc. Announces Cash Dividend for the Quarter of Fiscal Year 2022, Payable on Sep..
CI
08/11ResMed Inc. Reports Earnings Results for the Fourth Quarter Ended June 30, 2022
CI
08/11Earnings Reaction History: Resmed Inc, 80.0% Follow-Through In..
MT
08/02ResMed Acquires Germany-Based Mementor for Undisclosed Terms
MT
08/02ResMed Acquires Leipzig-based mementor witháInsomnia Digital Health Solution somnio
GL
08/02ResMed Acquires Leipzig-based mementor witháInsomnia Digital Health Solution somnio
AQ
08/02ResMed Inc. acquired mementor DE GmbH.
CI
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on RESMED, INC.